Weijian Hang

1.2k total citations
30 papers, 835 citations indexed

About

Weijian Hang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Weijian Hang has authored 30 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Physiology. Recurrent topics in Weijian Hang's work include Mitochondrial Function and Pathology (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Weijian Hang is often cited by papers focused on Mitochondrial Function and Pathology (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Weijian Hang collaborates with scholars based in China, United States and Poland. Weijian Hang's co-authors include Dao Wen Wang, Hongyang Shu, Ning Zhou, Yizhong Peng, Chen Chen, Jiali Nie, John M. Seubert, Yue Wu, Na Li and Anbing Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Cardiovascular Research.

In The Last Decade

Weijian Hang

29 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijian Hang China 17 363 236 136 115 108 30 835
Wenliang Zha China 14 388 1.1× 227 1.0× 106 0.8× 112 1.0× 83 0.8× 20 899
Rosa Bretón‐Romero United States 16 429 1.2× 184 0.8× 252 1.9× 139 1.2× 82 0.8× 22 875
Wenhai Sui China 16 358 1.0× 189 0.8× 101 0.7× 172 1.5× 79 0.7× 35 841
Bradley T. Andresen United States 19 562 1.5× 185 0.8× 165 1.2× 54 0.5× 99 0.9× 44 1.2k
Xue Dong China 18 509 1.4× 149 0.6× 115 0.8× 122 1.1× 71 0.7× 47 994
Wanrong Man China 16 364 1.0× 227 1.0× 121 0.9× 226 2.0× 78 0.7× 24 833
Ming Zhong China 17 302 0.8× 401 1.7× 66 0.5× 71 0.6× 111 1.0× 55 916
Soo Kyoung Choi South Korea 17 336 0.9× 176 0.7× 196 1.4× 161 1.4× 128 1.2× 62 935
Qiuhuan Yuan China 20 470 1.3× 133 0.6× 141 1.0× 182 1.6× 107 1.0× 44 1.1k

Countries citing papers authored by Weijian Hang

Since Specialization
Citations

This map shows the geographic impact of Weijian Hang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijian Hang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijian Hang more than expected).

Fields of papers citing papers by Weijian Hang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijian Hang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijian Hang. The network helps show where Weijian Hang may publish in the future.

Co-authorship network of co-authors of Weijian Hang

This figure shows the co-authorship network connecting the top 25 collaborators of Weijian Hang. A scholar is included among the top collaborators of Weijian Hang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijian Hang. Weijian Hang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Zhitong, et al.. (2024). Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insights. Frontiers of Medicine. 18(1). 31–45. 11 indexed citations
3.
Nie, Jiali, Yu Han, Weijian Hang, et al.. (2023). Homology-directed repair of an MYBPC3 gene mutation in a rat model of hypertrophic cardiomyopathy. Gene Therapy. 30(6). 520–527. 16 indexed citations
4.
Li, Huihui, Mingzhi Zhang, Quanyi Zhao, et al.. (2023). Self-recruited neutrophils trigger over-activated innate immune response and phenotypic change of cardiomyocytes in fulminant viral myocarditis. Cell Discovery. 9(1). 103–103. 27 indexed citations
5.
Chen, Jiehui, Yong Liu, Wei Zhang, et al.. (2022). DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy. BioFactors. 49(1). 173–184. 4 indexed citations
6.
Shu, Hongyang, Yizhong Peng, Weijian Hang, et al.. (2022). Emerging Roles of Ceramide in Cardiovascular Diseases. Aging and Disease. 13(1). 232–232. 42 indexed citations
7.
Li, Na, Weijian Hang, Hongyang Shu, & Ning Zhou. (2022). RBM20, a Therapeutic Target to Alleviate Myocardial Stiffness via Titin Isoforms Switching in HFpEF. Frontiers in Cardiovascular Medicine. 9. 928244–928244. 6 indexed citations
8.
Xu, Kai, Xiang Liu, Bin Wen, et al.. (2022). GSK-J4, a Specific Histone Lysine Demethylase 6A Inhibitor, Ameliorates Lipotoxicity to Cardiomyocytes via Preserving H3K27 Methylation and Reducing Ferroptosis. Frontiers in Cardiovascular Medicine. 9. 907747–907747. 15 indexed citations
9.
Shu, Hongyang, Weijian Hang, Min Zhang, et al.. (2022). Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of HSF1 to VEGF-A promoter. Acta Pharmacologica Sinica. 43(10). 2550–2561. 10 indexed citations
10.
11.
Hang, Weijian, Hongyang Shu, Wen Zheng, et al.. (2021). N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function. Frontiers in Pharmacology. 12. 636204–636204. 20 indexed citations
12.
Hu, Caiying, Qianying Zhang, Jiehui Chen, et al.. (2021). Protective Effect of Salidroside on Mitochondrial Disturbances via Reducing Mitophagy and Preserving Mitochondrial Morphology in OGD-induced Neuronal Injury. Current Medical Science. 41(5). 936–943. 16 indexed citations
13.
Shu, Hongyang, Yizhong Peng, Weijian Hang, Ning Zhou, & Dao Wen Wang. (2021). Trimetazidine in Heart Failure. Frontiers in Pharmacology. 11. 569132–569132. 46 indexed citations
14.
Shu, Hongyang, Weijian Hang, Jiali Nie, et al.. (2021). Trimetazidine Attenuates Heart Failure by Improving Myocardial Metabolism via AMPK. Frontiers in Pharmacology. 12. 707399–707399. 26 indexed citations
15.
Chen, Chen, Huihui Li, Weijian Hang, & Dao Wen Wang. (2020). Cardiac injuries in coronavirus disease 2019 (COVID-19). Journal of Molecular and Cellular Cardiology. 145. 25–29. 20 indexed citations
16.
Liang, Tao, et al.. (2019). Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress. Journal of Alzheimer s Disease. 71(2). 597–611. 9 indexed citations
17.
Hang, Weijian, et al.. (2019). China’s treatment regimen for fulminant myocarditis is bringing wonderful achievement to the world. Science China Life Sciences. 62(2). 282–284. 5 indexed citations
18.
Chen, Qingjie, et al.. (2018). Melatonin Mitigates Kainic Acid-Induced Neuronal Tau Hyperphosphorylation and Memory Deficits through Alleviating ER Stress. Frontiers in Molecular Neuroscience. 11. 5–5. 30 indexed citations
19.
Wang, Shimin, Weijian Hang, Wenjuan Zhang, et al.. (2017). LET-413/Erbin acts as a RAB-5 effector to promote RAB-10 activation during endocytic recycling. The Journal of Cell Biology. 217(1). 299–314. 34 indexed citations
20.
Chen, Qingjie, Weijian Hang, Yue Wu, et al.. (2017). Melatonin Mediates Protective Effects against Kainic Acid-Induced Neuronal Death through Safeguarding ER Stress and Mitochondrial Disturbance. Frontiers in Molecular Neuroscience. 10. 49–49. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenliang Zha Breakdown of academic impact, for papers by Rosa Bretón‐Romero Breakdown of academic impact, for papers by Wenhai Sui Breakdown of academic impact, for papers by Bradley T. Andresen Breakdown of academic impact, for papers by Xue Dong Breakdown of academic impact, for papers by Wanrong Man Breakdown of academic impact, for papers by Ming Zhong Breakdown of academic impact, for papers by Soo Kyoung Choi Breakdown of academic impact, for papers by Qiuhuan Yuan
Rankless by CCL
2026